Bone-marrow cells of a multiple myeloma patient. Red cells are healthy monocytes, green and yellow are plasma cells. Credit: Berend Snijder Lab / ETH Zurich
One of the main challenges is the cancer’s tendency to return even after treatment. This is because treatment makes the cancer cells more resistant to the drugs used, until eventually, after several rounds of treatment, no effective options remain.researchers have adapted their screening platform to look for ways out of this problem, and thereby offering new hope for more successful treatment outcomes.
The goal was to observe the behavior of cancer cells in response to various approved drugs and drug combinations in each biopsy. Based on the cells’ appearance, the researchers could determine the best treatment option for each patient.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: FoxNews - 🏆 9. / 87 Read more »
Source: SciTechDaily1 - 🏆 84. / 68 Read more »